Vivian Hernandez-Trujillo, MD
Las Vegas—A patient with primary immunodeficiency on immune globulin (IG) therapy receives the first and second doses of a messenger RNA COVID-19 vaccine as well as a booster dose, but no COVID-19 antibodies develop. Is the patient protected against the SARS-CoV-2 virus?
This isn’t a hypothetical situation; it’s a real case described by a clinician looking for answers at the IgNS 2021 Conference. He posed the question to Vivian Hernandez-Trujillo,